Anand A, Andrade C, Sudha S, Guido S, Venkataraman B V
Department of Pharmacology, St. John's Medical College, Bangalore, India.
J ECT. 2001 Sep;17(3):166-9. doi: 10.1097/00124509-200109000-00003.
Phenylephrine is a nonselective alpha-receptor agonist. This study examined whether the administration of phenylephrine immediately before electroconvulsive shocks (ECS) attenuated ECS-induced retrograde amnesia. Adult male Wistar rats received phenylephrine (0.25 mg/kg i.p.) or saline 3 min before each of three once-daily true or sham ECS. Retention of pre-ECS learning was studied 1 day after the ECS course using a passive avoidance task. Phenylephrine increased seizure duration in ECS-treated rats, and also enhanced recall in both true and sham ECS groups. The latter finding suggests that phenylephrine nonspecifically improves cognitive functions, perhaps through adrenergic mechanisms that improve memory consolidation and storage. Since phenylephrine increases blood pressure, its cognitive effects also weaken the hypothesis that ECT-induced cognitive impairment results from the seizure-related hypertensive surge.
去氧肾上腺素是一种非选择性α受体激动剂。本研究考察了在电惊厥休克(ECS)之前立即给予去氧肾上腺素是否会减轻ECS诱导的逆行性遗忘。成年雄性Wistar大鼠在每日一次的三次真实或假ECS之前3分钟接受去氧肾上腺素(0.25mg/kg腹腔注射)或生理盐水。在ECS疗程后1天,使用被动回避任务研究ECS前学习的记忆保持情况。去氧肾上腺素增加了接受ECS治疗大鼠的癫痫持续时间,并且在真实和假ECS组中均增强了记忆恢复。后一发现表明,去氧肾上腺素可能通过改善记忆巩固和存储的肾上腺素能机制非特异性地改善认知功能。由于去氧肾上腺素会升高血压,其认知效应也削弱了ECT诱导的认知障碍是由癫痫相关的高血压激增所致这一假说。